Veterans’ Pharmacy and Health Care Utilization Following Implementation of the Medicare Part D Pharmacy Benefit

2016 ◽  
Vol 74 (3) ◽  
pp. 328-344 ◽  
Author(s):  
Kevin T. Stroupe ◽  
Lauren Bailey ◽  
Walid F. Gellad ◽  
Katie Suda ◽  
Zhiping Huo ◽  
...  

We examined associations between enrollment in Medicare Part D pharmacy benefits and changes in medication acquisition from Department of Veterans Affairs (VA) pharmacies. We included all women and a random 10% sample of men who were VA enrollees, ≥65 years old as of January 1, 2004, and alive through December 2007. We used difference-in-differences models with propensity score weighting to examine changes in medication acquisition between 2005 (before Part D was implemented) and 2007 (after Part D implementation) for veterans who were or were not Part D enrolled. Of 231,716 veterans meeting inclusion criteria, 49,881 (21.5%) were enrolled. While 30-day medication supplies decreased from 26.2 to 23.4 for enrolled veterans, they increased from 36.6 to 37.4 for nonenrolled veterans (difference-in-differences: −4.0, p < .001). Reductions in 30-day supplies were greater among veterans who were required to pay VA copayments for some or all medications and who used VA and Medicare outpatient services.

2016 ◽  
Vol 38 (1) ◽  
pp. 22-25 ◽  
Author(s):  
Walid F. Gellad ◽  
Xinhua Zhao ◽  
Carolyn T. Thorpe ◽  
Joshua M. Thorpe ◽  
Florentina E. Sileanu ◽  
...  

2019 ◽  
Vol 179 (11) ◽  
pp. 1584 ◽  
Author(s):  
Joshua M. Thorpe ◽  
Carolyn T. Thorpe ◽  
Loren Schleiden ◽  
John Cashy ◽  
Ronald Carico ◽  
...  

2018 ◽  
Vol 108 (2) ◽  
pp. 248-255 ◽  
Author(s):  
Walid F. Gellad ◽  
Joshua M. Thorpe ◽  
Xinhua Zhao ◽  
Carolyn T. Thorpe ◽  
Florentina E. Sileanu ◽  
...  

2018 ◽  
Vol 169 (9) ◽  
pp. 593 ◽  
Author(s):  
Ron Carico ◽  
Xinhua Zhao ◽  
Carolyn T. Thorpe ◽  
Joshua M. Thorpe ◽  
Florentina E. Sileanu ◽  
...  

Author(s):  
Salva N Balbale ◽  
Lishan Cao ◽  
Itishree Trivedi ◽  
Jonah J Stulberg ◽  
Katie J Suda ◽  
...  

Abstract Disclaimer In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose We examined the prevalence of, and factors associated with, serious opioid-related adverse drug events (ORADEs) that led to an emergency department (ED) visit or hospitalization among patients with chronic gastrointestinal (GI) symptoms and disorders dually enrolled in the Department of Veterans Affairs (VA) and Medicare Part D. Methods In this retrospective cohort study, we used linked national patient-level data (April 1, 2011, to December 31, 2014) from the VA and Centers for Medicare and Medicaid Services to identify serious ORADEs among dually enrolled veterans with a chronic GI symptom or disorder. Outcome measures included serious ORADEs, defined as an ED visit attributed to an ORADE or a hospitalization where the principal or secondary reason for admission involved an opioid. We used multiple logistic regression models to determine factors independently associated with a serious ORADE. Results We identified 3,430 veterans who had a chronic GI symptom or disorder; were dually enrolled in the VA and Medicare Part D; and had a serious ORADE that led to an ED visit, hospitalization, or both. The period prevalence of having a serious ORADE was 2.4% overall and 4.4% among veterans with chronic opioid use (≥90 consecutive days). Veterans with serious ORADEs were more likely to be less than 40 years old, male, and white and to have chronic abdominal pain, functional GI disorders, chronic pancreatitis, or Crohn’s disease. They were also more likely to have used opioids chronically and at higher daily doses. Conclusion There may be a considerable burden of serious ORADEs among patients with chronic GI symptoms and disorders. Future quality improvement efforts should target this vulnerable population.


2018 ◽  
Vol 53 ◽  
pp. 5375-5401 ◽  
Author(s):  
Carolyn T. Thorpe ◽  
Walid F. Gellad ◽  
Maria K. Mor ◽  
John P. Cashy ◽  
John R. Pleis ◽  
...  

2010 ◽  
Vol 13 (3) ◽  
pp. A7
Author(s):  
FX Liu ◽  
GC Alexander ◽  
SY Crawford ◽  
AS Pickard ◽  
DR Hedeker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document